Future Directions in ATTR-CM Treatment

In this American College of Cardiology CardiaCast episode, Kevin M. Alexander, MD, and Sarah Cuddy, MBBCh, review new data on investigational and approved therapies, including findings from CARDIO-TTRansform and ATTRibute-CM, plus emerging evidence on extracardiac effects of treatment, specifically the effects of acoramidis on kidney function and the effects of vutrisiran on gastrointestinal events. Listen now for key insights shaping the future of ATTR-CM care.